HomeAbout UsServicesClientsResource CenterTransactionsContact
Resource Center
Sawaya Segalas News
September 3, 2014
Prestige Brands Holdings, Inc. Completes Purchase of Insight Pharmaceuticals Corporation

TARRYTOWN, NY — Prestige Brands Holdings, Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of Insight Pharmaceuticals Corporation ("Insight"), a marketer and distributor of feminine care and other over-the-counter ("OTC") healthcare products.
The closing followed the Federal Trade Commission's ("FTC") approval of the acquisition and was finalized pursuant to the terms of the purchase agreement announced on April 25, 2014. The acquisition will extend Prestige's portfolio of iconic OTC brands to include a leading feminine care platform in the U.S. and Canada anchored by Monistat®, the #1 brand in OTC yeast infection treatment. The acquisition will also add brands to Prestige's cough/cold, pain relief, ear care and dermatological platforms. This transaction is expected to result in pro forma revenues and adjusted EBITDA of approximately $800 million and $300 million, respectively, for the Company in fiscal 2015. The purchase of Insight will be immediately accretive to the Company's earnings per share and free cash flow per share, exclusive of transaction, integration and purchase accounting items.
Sawaya Segalas & Co., LLC acted as exclusive financial advisor to Prestige Brands on this transaction.
About Prestige Brands Holdings, Inc.
The Company markets and distributes brand name over-the-counter and household cleaning products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Chloraseptic® sore throat treatments, Clear Eyes® eye care products, Compound W® wart treatments, The Doctor's® NightGuard® dental protector, the Little Remedies® and PediaCare® lines of pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Dramamine® motion sickness treatment, BC® and Goody's® pain relievers, Beano® gas prevention, Debrox® earwax remover, and Gaviscon® antacid in Canada.

Featured News  12.22.16  |  
Featured News  06.30.16  |  
Featured News  09.05.14  |  
Featured News  04.25.14  |  
Featured News  04.25.14  |  
Our Case Studies
Noteworthy Industry Transactions

Discover Sawaya Segalas' Reviews of Recent Industry News and Transactions

Burts Bees
October 30, 2007

Clorox Acquires Burt's Bees

Learn More

View All Transaction    Profiles